Načítá se...
Sodium Iodide Symporter (NIS) in the Management of Patients with Thyroid Carcinoma
Although radioiodine has been applied in thyroid diseases including carcinoma for over 70 years, it was only in 1996 that the basic molecular mechanism of iodine uptake was identified. Iodide is actively transported into the thyroid via a membrane glycoprotein known as sodium iodide symporter (NIS)....
Uloženo v:
| Vydáno v: | Nucl Med Mol Imaging |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6177348/ https://ncbi.nlm.nih.gov/pubmed/30344779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13139-018-0540-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|